News India Talks

Jubilant Co. is set to sell a $139 million interest in a US corporation

<p><strong>NEW DELHI:</strong> For $139.4 million, Jubilant Pharma, a division of Jubilant Pharmova, will sell its whole 25.8% ownership in Sofie Biosciences, a US company. According to a statement from the firm, Singapore-based Jubilant Pharma contributed $25 million to Sofie in November 2020.</p>
<p><img decoding=”async” class=”alignnone wp-image-382453″ src=”” alt=” jubilant co is set to sell a 139 million interest in a us corporation 107274025 1″ width=”1017″ height=”572″ title=”Jubilant Co. is set to sell a $139 million interest in a US corporation 15″ srcset=” 400w,×220.png 390w,×84.png 150w” sizes=”(max-width: 1017px) 100vw, 1017px” /></p>
<p>Sofie is a company that develops and provides molecular medicines and diagnostics (theranostics). It possesses an advanced contract manufacturing services network, a radiopharmaceutical production and distribution network, and valuable therapeutic intellectual property.<br />
It and several private equity groups have recently finalized their merger deal.</p>

Related posts

Which Should I Buy Between the Tata Harrier and Mahindra XUV700? A comparison of all features, specifications, and costs

Hiring Trend: Employers Want These Soft Skills From Job Seekers, Not Just Tech Expertise

Prepare for the Honda D110 Dream Deluxe with this breakdown of features and specifications

Experts Suggest Buying Five Stocks: EPL Ltd. To Swan Energy

The cryptocurrency market remains volatile as it struggles with economic indicators and investor sentiment

Shein, China’s $60 billion fashion retailer, files for an IPO in the US: Report